SALT LAKE CITY, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and…
Oral presentation at 2025 ASCO Gastrointestinal Cancers Symposium today highlights evorpacept as the first CD47 blocker to show substantial tumor…
REYKJAVIK, Iceland, Jan. 22, 2025 /PRNewswire/ -- Complete recombination map of the human-genome, a major step in genetics Scientists at…
WILMINGTON, Mass., Jan. 22, 2025 /PRNewswire/ -- Analog Devices, Inc. (NASDAQ: ADI) today announced the appointment of Andrea F. Wainer, a seasoned…
CHICAGO, IL / ACCESS Newswire / January 22, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a…
Transaction Eliminates More Than $20 Million in Debt, and Other Financial Obligations, Provides $2 million in Cash and Significantly Enhances…
VANCOUVER, British Columbia, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company at the forefront…
- ARCATUS®, Branded as XIPERE® in the U.S., is the First Globally Approved Suprachoroidal Therapy - - Continued Global Expansion…
PANProfiler Colon achieved 92.69% positive and 94.05% negative agreement for MSI/dMMR detection Real-world blinded validation on 3178 colorectal cancer patient samplesData…
SON-1010, after receipt of data suggesting clinical benefit when administered as a monotherapy in patients with advanced solid tumors, enters…